PMID: 8281612Sep 1, 1993Paper

EGF receptor in neoplasia and metastasis

Cancer Metastasis Reviews
K KhazaieR B Lichtner

Abstract

EGFR is a member of the tyrosine kinase family of cell surface receptors with a wide range of expression throughout development and in a variety of different cell types. The receptor can transmit signals to cells: i) upon interaction with ligands such as EGF, TGF alpha, amphiregulin or heparin binding EGF, ii) upon truncation or mutation of extracellular and/or intracellular domains, iii) upon amplification of a basal receptor activity (in the absence of ligand) through cooperation with other cellular signaling pathways or nuclear events (e.g. expression of v-erbA). The activated EGFR can exert pleiotropic functions on cells, depending on their tissue origin and state of differentiation. Under certain conditions it can also contribute to neoplasia and development of metastases. Such conditions can exist upon aberrant receptor/ligand expression and activation (e.g. in the wrong cell; at the wrong time; in the wrong amounts). Aberrant signalling can also occur through constitutive EGFR activation. Oncogenic potential of EGFR has been demonstrated in a wide range of experimental animals. EGFR is also implicated in human cancer, where it may contribute both to the initiation (glioblastoma) and progression (epithelial tumors) of the...Continue Reading

References

Jun 1, 1978·Journal of the National Cancer Institute·E B Briles, S Kornfeld
Apr 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·S Cohen, G Carpenter
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BilousJ M Mathijs
Feb 1, 1992·Molecular and Cellular Biology·N RedemannA Ullrich
Jan 1, 1992·Progress in Growth Factor Research·S A Prigent, N R Lemoine
Dec 2, 1992·International Journal of Cancer. Journal International Du Cancer·M MauriziG Cadoni
Dec 2, 1992·International Journal of Cancer. Journal International Du Cancer·S HuangS Chakrabarty
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S K HanksS K Patel
Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ScambiaS Mancuso
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M ChaffanetA L Benabid
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D M Ignar-TrowbridgeK S Korach
Jan 1, 1992·Journal of the American Society of Nephrology : JASN·L G FineH E Abboud
Jun 1, 1992·Seminars in Cell Biology·J BehrensW Birchmeier
Nov 11, 1991·International Journal of Cancer. Journal International Du Cancer·H MizoguchiM Kuwano
Feb 1, 1991·British Journal of Cancer·N L TuziW J Gullick
Aug 15, 1991·Biochemical and Biophysical Research Communications·P A HumphreyD D Bigner
Jan 1, 1991·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·H ArnholdtU Löhrs
Jan 1, 1991·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·H ArnholdtU Löhrs
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A HumphreyD D Bigner
Jan 1, 1991·Archives of Dermatological Research·M F te PasM Ponec
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·L J KornbergR L Juliano

❮ Previous
Next ❯

Citations

Mar 17, 1997·International Journal of Cancer. Journal International Du Cancer·S B KondapakaK B Reddy
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K P De JongE G De Vries
Jan 8, 1999·Brain Tumor Pathology·N SugawaT Okabe
Jun 27, 2006·Pathology Oncology Research : POR·Yukihiro HiraishiShigeyuki Fujita
Apr 1, 1995·Endocrine Pathology·Dorothee LubkeDieter K. Ludecke
Apr 7, 2007·Cancer Immunology, Immunotherapy : CII·Greta GarridoLuis E Fernández
Feb 9, 2008·Neurosurgical Review·Lee A SelznickJohn Sampson
Apr 17, 2007·Diseases of the Colon and Rectum·Ghaith KhairJohn Greenman
Sep 29, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Ming-Rong ZhangKazutoshi Suzuki
Oct 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J T PriceN E Haites
Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Jun 1, 1996·Critical Reviews in Oncology/hematology·A Lupulescu
Nov 26, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rosemarie B Lichtner
Oct 18, 2000·Critical Reviews in Oncology/hematology·R C BatesJ D Yates
Mar 5, 2004·Breast Cancer Research and Treatment·James M Rae, Marc E Lippman
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·M C MaaS J Parsons
Aug 23, 2006·Acta Pharmacologica Sinica·Jian LiHua-liang Jiang
Feb 24, 2001·Molecular Pathology : MP·I J Uings, S N Farrow
Apr 3, 2001·Annual Review of Neuroscience·R Wechsler-Reya, M P Scott
Aug 29, 2012·Biochemistry Research International·Jackie L JohnsonSrikumar P Chellappan
Jul 23, 2004·American Journal of Respiratory Cell and Molecular Biology
Sep 29, 2011·Nutrition Journal·Richard B KreiderMen-Hwei Tsai
Apr 9, 2009·Journal of Cell Science·Joshua Z Rappoport, Sanford M Simon
Jan 1, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Markus D Siegelin, Alain C Borczuk
Nov 11, 2008·Journal of Endocrinological Investigation·S GelminiE Lazzeri
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A TiceS J Parsons
May 5, 2007·Journal of Biomedical Optics·Kristen E AdamsEva M Sevick-Muraca
Jul 13, 2006·Expert Review of Anticancer Therapy·Niklaus G SchaeferChristoph Renner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.